US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Enveric Biosciences

5.53

+0.29005.53%

Post-market: 5.42-0.1100-1.99%17:46 EST

Volume:81.34K

Turnover:447.08K

Market Cap:3.30M

PE:-0.04

High:5.79

Open:5.25

Low:5.20

Close:5.24

52wk High:96.30

52wk Low:4.55

Shares:597.00K

Float Shares:594.40K

Volume Ratio:0.01

T/O Rate:13.68%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-126.0499

EPS(LYR):-228.4745

ROE:-262.78%

ROA:-133.22%

PB:0.96

PE(LYR):-0.02

Loading ...

Overview Company News Filings

Enveric Biosciences Inc announces date for special stockholder meeting

Enveric Biosciences completes key manufacturing milestones for EB-003

Enveric Biosciences Achieves Key Manufacturing Milestones for EB-003, Paving Way for Human Clinical Trials

Enveric Biosciences Successfully Completes Key Manufacturing Milestones in Support of Planned Ind and Clinical Trials

THOMSON REUTERS

BRIEF-Enveric Biosciences Says Selling Stockholders Are Offering On A Resale Basis An Aggregate Of 4.8 Million Shares Of Common Stock - SEC Filing

Enveric Biosciences files to sell 5.02M shares of common stock for holders

Enveric Biosciences Inc: Selling Stockholders Are Offering on a Resale Basis an Aggregate of 4.8 Mln Shares of Common Stock - SEC Filing

THOMSON REUTERS

Enveric Biosciences Closes Warrant Exercise Deal

Enveric Biosciences Expects to Receive $2.2 Million From Exercise of Warrants

MT Newswires Live

Enveric Biosciences to Submit Investigational New Drug Application for Depression Medication

MT Newswires Live

Enveric Biosciences receives FDA response, streamlines path for EB-003

Enveric Biosciences Receives FDA Response and Streamlines Plans for Eb-003 Ind Submission

THOMSON REUTERS

Enveric Biosciences Inc - Expects to File Ind for Eb-003 in Early 2026

THOMSON REUTERS

Enveric Biosciences to Present at H.C. Wainwright 27th Annual Global Investment Conference

Enveric Biosciences Relocates Headquarters to Cambridge, MA to Advance Neuroplastogen Research

Enveric Biosciences Faces Nasdaq Delisting Risk Due to Stockholders' Equity Shortfall

Enveric Biosciences Inc - Completes Pre-Ind Dose Range Finding Studies for Lead Candidate Eb-003

THOMSON REUTERS

Enveric Biosciences Advances Lead Candidate EB-003 Towards Clinical Trials with Successful Pre-IND Study Completion

Enveric Biosciences Q2 EPS $(0.97) Up From $(3.72) YoY

Enveric Biosciences Reports Q2 2025 Net Loss of $2.5M, EPS at $0.97, Up from $1.9M Loss, $3.72 EPS in Q2 2024

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/ENVB/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ENVB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ENVB\",,,,,undefined,":{"symbol":"ENVB","market":"US","secType":"STK","nameCN":"Enveric Biosciences","latestPrice":5.53,"timestamp":1766005200000,"preClose":5.24,"halted":0,"volume":81343,"hourTrading":{"tag":"盘后","latestPrice":5.42,"preClose":5.53,"latestTime":"17:46 EST","volume":286,"amount":1546.6008558,"timestamp":1766011613881},"delay":0,"floatShares":594400,"shares":597000,"eps":-126.04987,"marketStatus":"Post-Mkt","change":0.29,"latestTime":"12-17 17:49:54 EST","open":5.25,"high":5.79,"low":5.2,"amount":447077.20951109997,"amplitude":0.112595,"askPrice":5.42,"askSize":120,"bidPrice":5.28,"bidSize":500,"shortable":3,"etf":0,"ttmEps":-126.04987,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1766019600000},"marketStatusCode":4,"adr":0,"exchange":"NASDAQ","adjPreClose":5.24,"preHourTrading":{"tag":"盘前","latestPrice":5.2651,"preClose":5.24,"latestTime":"09:22 EST","volume":1518,"amount":7989.7950528,"timestamp":1765981357938},"postHourTrading":{"tag":"盘后","latestPrice":5.42,"preClose":5.53,"latestTime":"17:46 EST","volume":286,"amount":1546.6008558,"timestamp":1766011613881},"volumeRatio":0.010917,"impliedVol":6.7116,"impliedVolPercentile":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ENVB\",,,,,undefined,":{"symbol":"ENVB","floatShares":594400,"roa":"-133.22%","roe":"-262.78%","lyrEps":-228.474528,"volumeRatio":0.010917,"shares":597000,"dividePrice":0,"high":5.79,"amplitude":0.112595,"preClose":5.24,"low":5.2,"week52Low":4.55,"pbRate":"0.96","week52High":96.3,"institutionHeld":0.0128,"latestPrice":5.53,"committee":0.612903,"eps":-126.04987,"divideRate":0,"volume":81343,"delay":0,"ttmEps":-126.04987,"open":5.25,"prevYearClose":64.512,"prevWeekClose":5.43,"prevMonthClose":5.74,"prevQuarterClose":7.6728,"fiveDayClose":10.33,"twentyDayClose":5.67,"sixtyDayClose":6.9876},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ENVB\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-14","symbol":"ENVB","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1763096400000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2025-10-28","symbol":"ENVB","defaultRemindTime":1761658200000,"type":"split","dateTimestamp":1761624000000,"forFactor":12,"toFactor":1,"ratio":12},{"market":"US","date":"2025-08-14","symbol":"ENVB","fiscalQuarterEnding":"2025/06","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1755144000000,"reportTimeType":"pre","actualEps":-0.97},{"market":"US","date":"2025-05-14","symbol":"ENVB","fiscalQuarterEnding":"2025/03","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747195200000,"reportTimeType":"post","actualEps":-1.22},{"market":"US","date":"2025-03-28","symbol":"ENVB","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1743134400000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ENVB\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ENVB\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ENVB\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ENVB","date":"2025-12-16","current":-0.041571,"percent":0.515574,"low":-320.639018,"twenty":-3.067557,"median":-0.332103,"eighty":-0.17461,"high":-0.058065,"avg":-9.050512,"sd":35.804328,"marketCap":3199802},"quantilePoints":[{"date":"2020-12-31","current":-280.476842,"twenty":-280.476842,"median":-280.476842,"eighty":-280.476842,"marketCap":792872691},{"date":"2021-01-08","current":-298.911939,"twenty":-298.911939,"median":-271.259293,"eighty":-259.408159,"marketCap":844986389},{"date":"2021-01-15","current":-140.596002,"twenty":-298.911939,"median":-259.408159,"eighty":-149.472012,"marketCap":397447182},{"date":"2021-01-22","current":-139.885921,"twenty":-284.163861,"median":-149.827052,"eighty":-143.081285,"marketCap":395439873},{"date":"2021-01-29","current":-131.364951,"twenty":-265.728764,"median":-148.761931,"eighty":-140.453986,"marketCap":371352165},{"date":"2021-02-05","current":-151.602254,"twenty":-259.934876,"median":-149.472012,"eighty":-140.453986,"marketCap":428560471},{"date":"2021-02-12","current":-175.045989,"twenty":-257.30129,"median":-150.892174,"eighty":-141.448099,"marketCap":494832954},{"date":"2021-02-19","current":-160.43665,"twenty":-213.420734,"median":-152.134815,"eighty":-142.300196,"marketCap":468056279},{"date":"2021-02-26","current":-125.559118,"twenty":-179.541263,"median":-151.602254,"eighty":-140.101005,"marketCap":366304914},{"date":"2021-03-05","current":-102.062675,"twenty":-175.516923,"median":-149.649532,"eighty":-134.616645,"marketCap":297756626},{"date":"2021-03-12","current":-135.838811,"twenty":-174.400276,"median":-148.05185,"eighty":-132.754903,"marketCap":396294790},{"date":"2021-03-19","current":-136.138295,"twenty":-173.119122,"median":-143.613845,"eighty":-132.754903,"marketCap":397168501},{"date":"2021-03-26","current":-116.477996,"twenty":-169.027537,"median":-141.661123,"eighty":-131.048595,"marketCap":339811742},{"date":"2021-04-01","current":-8.8686,"twenty":-166.237335,"median":-140.244394,"eighty":-126.440234,"marketCap":60880065},{"date":"2021-04-09","current":-7.905238,"twenty":-163.520558,"median":-138.8208,"eighty":-117.173389,"marketCap":54266895},{"date":"2021-04-16","current":-6.743536,"twenty":-159.459183,"median":-137.674471,"eighty":-107.720259,"marketCap":46292190},{"date":"2021-04-23","current":-6.630199,"twenty":-155.86274,"median":-135.909644,"eighty":-43.943438,"marketCap":45514170},{"date":"2021-04-30","current":-6.743536,"twenty":-152.52536,"median":-133.63602,"eighty":-8.20558,"marketCap":46292190},{"date":"2021-05-07","current":-6.488528,"twenty":-152.170319,"median":-132.167492,"eighty":-7.344221,"marketCap":44541645},{"date":"2021-05-14","current":-5.411829,"twenty":-151.824571,"median":-131.364951,"eighty":-6.941875,"marketCap":37150455},{"date":"2021-05-21","current":-6.452474,"twenty":-151.616192,"median":-128.055137,"eighty":-6.726536,"marketCap":58181480},{"date":"2021-05-28","current":-5.29008,"twenty":-151.03419,"median":-123.896977,"eighty":-6.596198,"marketCap":47700257},{"date":"2021-06-04","current":-5.59847,"twenty":-150.111085,"median":-118.216479,"eighty":-6.465861,"marketCap":50480990},{"date":"2021-06-11","current":-5.645915,"twenty":-149.756044,"median":-112.026608,"eighty":-6.142851,"marketCap":50908795},{"date":"2021-06-18","current":-5.100301,"twenty":-149.18798,"median":-107.569653,"eighty":-5.892627,"marketCap":45989037},{"date":"2021-06-25","current":-5.147746,"twenty":-147.625802,"median":-99.309185,"eighty":-5.745548,"marketCap":46416842},{"date":"2021-07-02","current":-5.205428,"twenty":-145.495559,"median":-8.500256,"eighty":-5.660148,"marketCap":46936956},{"date":"2021-07-09","current":-5.538195,"twenty":-143.791365,"median":-8.273582,"eighty":-5.645915,"marketCap":49937492},{"date":"2021-07-16","current":-4.706277,"twenty":-143.436325,"median":-7.777734,"eighty":-5.456136,"marketCap":42436152},{"date":"2021-07-23","current":-4.563663,"twenty":-142.726244,"median":-7.31022,"eighty":-5.408691,"marketCap":41150208},{"date":"2021-07-30","current":-4.539894,"twenty":-141.661123,"median":-7.026878,"eighty":-5.313802,"marketCap":40935884},{"date":"2021-08-06","current":-4.563663,"twenty":-140.596002,"median":-6.885207,"eighty":-5.266357,"marketCap":41150208},{"date":"2021-08-13","current":-4.047924,"twenty":-140.244394,"median":-6.729369,"eighty":-5.171468,"marketCap":36863728},{"date":"2021-08-20","current":-3.953786,"twenty":-140.244394,"median":-6.630199,"eighty":-5.062813,"marketCap":36006432},{"date":"2021-08-27","current":-4.259734,"twenty":-139.885921,"median":-6.531029,"eighty":-4.910522,"marketCap":38792644},{"date":"2021-09-03","current":-6.189558,"twenty":-137.755679,"median":-6.460194,"eighty":-4.89643,"marketCap":56367212},{"date":"2021-09-10","current":-8.119382,"twenty":-137.690713,"median":-6.488528,"eighty":-4.907704,"marketCap":73941780},{"date":"2021-09-17","current":-8.615408,"twenty":-137.674471,"median":-6.531029,"eighty":-4.93589,"marketCap":78459000},{"date":"2021-09-24","current":-7.719405,"twenty":-136.44553,"median":-6.630199,"eighty":-4.943621,"marketCap":70299264},{"date":"2021-10-01","current":-7.099096,"twenty":-136.01204,"median":-6.675957,"eighty":-4.993123,"marketCap":64650216},{"date":"2021-10-08","current":-6.651095,"twenty":-135.867144,"median":-6.630199,"eighty":-5.02439,"marketCap":60570348},{"date":"2021-10-15","current":-6.513248,"twenty":-135.384078,"median":-6.633456,"eighty":-5.056077,"marketCap":59315004},{"date":"2021-10-22","current":-6.099709,"twenty":-133.962895,"median":-6.630199,"eighty":-5.092803,"marketCap":55548972},{"date":"2021-10-29","current":-6.065247,"twenty":-133.048609,"median":-6.595082,"eighty":-5.138257,"marketCap":55235136},{"date":"2021-11-05","current":-7.168019,"twenty":-132.60805,"median":-6.616633,"eighty":-5.155861,"marketCap":65277888},{"date":"2021-11-12","current":-6.168632,"twenty":-131.947213,"median":-6.595082,"eighty":-5.168752,"marketCap":56176644},{"date":"2021-11-19","current":-4.517674,"twenty":-131.506654,"median":-6.513248,"eighty":-5.056077,"marketCap":50841432},{"date":"2021-11-26","current":-4.043597,"twenty":-131.392262,"median":-6.513248,"eighty":-4.988793,"marketCap":45506220},{"date":"2021-12-03","current":-3.206991,"twenty":-130.890416,"median":-6.474361,"eighty":-4.904885,"marketCap":36091140},{"date":"2021-12-10","current":-3.346425,"twenty":-129.238643,"median":-6.444325,"eighty":-4.774013,"marketCap":37660320},{"date":"2021-12-17","current":-3.290652,"twenty":-127.996491,"median":-6.388385,"eighty":-4.697107,"marketCap":37032648},{"date":"2021-12-23","current":-2.983896,"twenty":-126.880793,"median":-6.32554,"eighty":-4.644478,"marketCap":33580452},{"date":"2021-12-31","current":-2.59348,"twenty":-124.894262,"median":-6.306478,"eighty":-4.563663,"marketCap":29186748},{"date":"2022-01-07","current":-2.34194,"twenty":-122.70994,"median":-6.254322,"eighty":-4.549402,"marketCap":26355947},{"date":"2022-01-14","current":-2.088169,"twenty":-119.844223,"median":-6.189558,"eighty":-4.526562,"marketCap":23500039},{"date":"2022-01-21","current":-1.761335,"twenty":-117.868782,"median":-6.167806,"eighty":-4.473884,"marketCap":19821881},{"date":"2022-01-28","current":-1.672934,"twenty":-115.958667,"median":-6.099709,"eighty":-4.269148,"marketCap":18827021},{"date":"2022-02-04","current":-1.728986,"twenty":-113.139455,"median":-6.063516,"eighty":-4.160722,"marketCap":19457832},{"date":"2022-02-11","current":-0.97441,"twenty":-109.726724,"median":-5.946223,"eighty":-4.044462,"marketCap":10965906},{"date":"2022-02-18","current":-1.307232,"twenty":-107.870866,"median":-5.883138,"eighty":-3.800914,"marketCap":14711450},{"date":"2022-02-25","current":-1.31751,"twenty":-107.569653,"median":-5.811971,"eighty":-3.513747,"marketCap":14827122},{"date":"2022-03-04","current":-1.205382,"twenty":-107.569653,"median":-5.752665,"eighty":-3.318539,"marketCap":13565240},{"date":"2022-03-11","current":-1.298822,"twenty":-102.062675,"median":-5.686169,"eighty":-3.206991,"marketCap":14616809},{"date":"2022-03-18","current":-1.277798,"twenty":-96.555696,"median":-5.645915,"eighty":-3.067557,"marketCap":14380206},{"date":"2022-03-25","current":-1.710427,"twenty":-8.8686,"median":-5.59847,"eighty":-2.900235,"marketCap":19248970},{"date":"2022-04-01","current":-0.335415,"twenty":-8.753254,"median":-5.473396,"eighty":-2.691084,"marketCap":16427585},{"date":"2022-04-08","current":-0.311257,"twenty":-8.615408,"median":-5.443118,"eighty":-2.412494,"marketCap":15244420},{"date":"2022-04-14","current":-0.322424,"twenty":-8.523286,"median":-5.408691,"eighty":-2.281147,"marketCap":15791305},{"date":"2022-04-22","current":-0.299018,"twenty":-8.454921,"median":-5.348648,"eighty":-1.926394,"marketCap":14644950},{"date":"2022-04-29","current":-0.289999,"twenty":-8.307583,"median":-5.29008,"eighty":-1.849012,"marketCap":14203235},{"date":"2022-05-06","current":-0.243079,"twenty":-8.24436,"median":-5.271546,"eighty":-1.800544,"marketCap":11905266},{"date":"2022-05-13","current":-0.209689,"twenty":-8.175607,"median":-5.205428,"eighty":-1.74622,"marketCap":10536900},{"date":"2022-05-20","current":-0.222689,"twenty":-8.127555,"median":-5.183329,"eighty":-1.725052,"marketCap":11190187},{"date":"2022-05-27","current":-0.215875,"twenty":-8.047524,"median":-5.147746,"eighty":-1.672265,"marketCap":10847738},{"date":"2022-06-03","current":-0.223528,"twenty":-7.988206,"median":-5.062813,"eighty":-1.556624,"marketCap":11232335},{"date":"2022-06-10","current":-0.230658,"twenty":-7.927398,"median":-5.012525,"eighty":-1.435245,"marketCap":11590590},{"date":"2022-06-17","current":-0.195325,"twenty":-7.876446,"median":-4.943968,"eighty":-1.350027,"marketCap":9815122},{"date":"2022-06-24","current":-0.190817,"twenty":-7.802113,"median":-4.910522,"eighty":-1.322369,"marketCap":9588579},{"date":"2022-07-01","current":-0.222899,"twenty":-7.691735,"median":-4.844076,"eighty":-1.294057,"marketCap":11200724},{"date":"2022-07-08","current":-0.253304,"twenty":-7.629603,"median":-4.77312,"eighty":-1.254625,"marketCap":12728575},{"date":"2022-07-15","current":-0.166912,"twenty":-7.516722,"median":-4.706277,"eighty":-1.216688,"marketCap":8387372},{"date":"2022-07-22","current":-0.202559,"twenty":-7.384727,"median":-4.682931,"eighty":-0.964683,"marketCap":10178645},{"date":"2022-07-29","current":-0.149083,"twenty":-7.33624,"median":-4.63497,"eighty":-0.340611,"marketCap":7491475},{"date":"2022-08-05","current":-0.224524,"twenty":-7.302457,"median":-4.564672,"eighty":-0.322252,"marketCap":11282352},{"date":"2022-08-12","current":-0.202085,"twenty":-7.264512,"median":-4.563663,"eighty":-0.311365,"marketCap":10535171},{"date":"2022-08-19","current":-0.204803,"twenty":-7.223157,"median":-4.551779,"eighty":-0.300589,"marketCap":10676899},{"date":"2022-08-26","current":-0.188492,"twenty":-7.165309,"median":-4.539894,"eighty":-0.289913,"marketCap":9826527},{"date":"2022-09-02","current":-0.167649,"twenty":-7.150287,"median":-4.517674,"eighty":-0.271682,"marketCap":8739940},{"date":"2022-09-09","current":-0.163722,"twenty":-7.133557,"median":-4.481832,"eighty":-0.254675,"marketCap":8535220},{"date":"2022-09-16","current":-0.177315,"twenty":-7.099096,"median":-4.397279,"eighty":-0.239045,"marketCap":9243864},{"date":"2022-09-23","current":-0.180988,"twenty":-7.083546,"median":-4.236199,"eighty":-0.230448,"marketCap":9435350},{"date":"2022-09-30","current":-0.168231,"twenty":-7.030173,"median":-4.183032,"eighty":-0.228141,"marketCap":8770303},{"date":"2022-10-07","current":-0.159062,"twenty":-7.026878,"median":-4.148603,"eighty":-0.224681,"marketCap":8292301},{"date":"2022-10-14","current":-0.136339,"twenty":-7.026878,"median":-4.043597,"eighty":-0.222899,"marketCap":7107686},{"date":"2022-10-21","current":-0.149893,"twenty":-6.989729,"median":-3.865786,"eighty":-0.220173,"marketCap":7814298},{"date":"2022-10-28","current":-0.137535,"twenty":-6.885207,"median":-3.625294,"eighty":-0.217815,"marketCap":7170034},{"date":"2022-11-04","current":-0.122386,"twenty":-6.885207,"median":-3.499804,"eighty":-0.214826,"marketCap":6380291},{"date":"2022-11-11","current":-0.133947,"twenty":-6.823403,"median":-3.346425,"eighty":-0.209794,"marketCap":6982990},{"date":"2022-11-18","current":-0.118932,"twenty":-6.823403,"median":-3.290652,"eighty":-0.209335,"marketCap":6172464},{"date":"2022-11-25","current":-0.123738,"twenty":-6.759509,"median":-3.248822,"eighty":-0.207205,"marketCap":6421857},{"date":"2022-12-02","current":-0.124138,"twenty":-6.743536,"median":-3.151217,"eighty":-0.203146,"marketCap":6442640},{"date":"2022-12-09","current":-0.104917,"twenty":-6.720869,"median":-3.025727,"eighty":-0.201787,"marketCap":5445070},{"date":"2022-12-16","current":-0.082091,"twenty":-6.691485,"median":-2.956009,"eighty":-0.196867,"marketCap":4260455},{"date":"2022-12-23","current":-0.070478,"twenty":-6.657987,"median":-2.872348,"eighty":-0.191082,"marketCap":3657756},{"date":"2022-12-30","current":-0.083293,"twenty":-6.651095,"median":-2.75383,"eighty":-0.189087,"marketCap":4322803},{"date":"2023-01-06","current":-0.109722,"twenty":-6.651095,"median":-2.596408,"eighty":-0.188295,"marketCap":5694462},{"date":"2023-01-13","current":-0.113326,"twenty":-6.651095,"median":-2.412494,"eighty":-0.183494,"marketCap":5881506},{"date":"2023-01-20","current":-0.112525,"twenty":-6.648218,"median":-2.314611,"eighty":-0.177375,"marketCap":5839941},{"date":"2023-01-27","current":-0.114528,"twenty":-6.635409,"median":-2.174061,"eighty":-0.173271,"marketCap":5943855},{"date":"2023-02-03","current":-0.115328,"twenty":-6.630199,"median":-1.930051,"eighty":-0.170174,"marketCap":5985420},{"date":"2023-02-10","current":-0.105718,"twenty":-6.630199,"median":-1.867724,"eighty":-0.168007,"marketCap":5486635},{"date":"2023-02-17","current":-0.100111,"twenty":-6.627486,"median":-1.840534,"eighty":-0.165234,"marketCap":5195677},{"date":"2023-02-24","current":-0.086656,"twenty":-6.616633,"median":-1.809474,"eighty":-0.163118,"marketCap":4497378},{"date":"2023-03-03","current":-0.077686,"twenty":-6.616633,"median":-1.767889,"eighty":-0.157267,"marketCap":4031845},{"date":"2023-03-10","current":-0.071279,"twenty":-6.573531,"median":-1.748228,"eighty":-0.149525,"marketCap":3699322},{"date":"2023-03-17","current":-0.072481,"twenty":-6.513248,"median":-1.728986,"eighty":-0.148152,"marketCap":3761670},{"date":"2023-03-24","current":-0.065273,"twenty":-6.513248,"median":-1.710427,"eighty":-0.147103,"marketCap":3387581},{"date":"2023-03-31","current":-0.066642,"twenty":-6.513248,"median":-1.677431,"eighty":-0.143493,"marketCap":3458658},{"date":"2023-04-06","current":-0.058065,"twenty":-6.513248,"median":-1.669217,"eighty":-0.140804,"marketCap":3013492},{"date":"2023-04-14","current":-0.153018,"twenty":-6.493472,"median":-1.471687,"eighty":-0.141803,"marketCap":2826448},{"date":"2023-04-21","current":-0.184522,"twenty":-6.488528,"median":-1.451598,"eighty":-0.142443,"marketCap":3408364},{"date":"2023-04-28","current":-0.199644,"twenty":-6.465861,"median":-1.415623,"eighty":-0.143307,"marketCap":3687684},{"date":"2023-05-05","current":-0.216026,"twenty":-6.454018,"median":-1.348812,"eighty":-0.144467,"marketCap":3990280},{"date":"2023-05-12","current":-0.187852,"twenty":-6.445955,"median":-1.329658,"eighty":-0.145026,"marketCap":3469881},{"date":"2023-05-19","current":-0.400593,"twenty":-6.444325,"median":-1.303495,"eighty":-0.145108,"marketCap":7460992},{"date":"2023-05-26","current":-0.431838,"twenty":-6.409959,"median":-1.29088,"eighty":-0.146704,"marketCap":8042908},{"date":"2023-06-02","current":-0.495442,"twenty":-6.385788,"median":-1.277798,"eighty":-0.147313,"marketCap":9227523},{"date":"2023-06-09","current":-0.454155,"twenty":-6.354725,"median":-1.236918,"eighty":-0.147482,"marketCap":8458562},{"date":"2023-06-16","current":-0.430722,"twenty":-6.32246,"median":-1.214726,"eighty":-0.14774,"marketCap":8022126},{"date":"2023-06-23","current":-0.422911,"twenty":-6.308675,"median":-1.16894,"eighty":-0.148001,"marketCap":7876647},{"date":"2023-06-30","current":-0.359307,"twenty":-6.306478,"median":-0.962251,"eighty":-0.148261,"marketCap":6692032},{"date":"2023-07-07","current":-0.324715,"twenty":-6.306478,"median":-0.516643,"eighty":-0.148697,"marketCap":6047768},{"date":"2023-07-14","current":-0.321367,"twenty":-6.306478,"median":-0.47703,"eighty":-0.149083,"marketCap":5985420},{"date":"2023-07-21","current":-0.320252,"twenty":-6.272017,"median":-0.459734,"eighty":-0.149096,"marketCap":5964637},{"date":"2023-07-28","current":-0.282312,"twenty":-6.236627,"median":-0.457502,"eighty":-0.149525,"marketCap":5258025},{"date":"2023-08-04","current":-0.281197,"twenty":-6.233521,"median":-0.440764,"eighty":-0.149643,"marketCap":5237242},{"date":"2023-08-11","current":-0.313556,"twenty":-6.189558,"median":-0.43128,"eighty":-0.149643,"marketCap":5839941},{"date":"2023-08-18","current":-0.212948,"twenty":-6.168632,"median":-0.422911,"eighty":-0.149893,"marketCap":4725393},{"date":"2023-08-25","current":-0.21198,"twenty":-6.167806,"median":-0.412868,"eighty":-0.150292,"marketCap":4703914},{"date":"2023-09-01","current":-0.209076,"twenty":-6.120184,"median":-0.400593,"eighty":-0.15118,"marketCap":4639476},{"date":"2023-09-08","current":-0.217302,"twenty":-6.103804,"median":-0.395014,"eighty":-0.151678,"marketCap":4822025},{"date":"2023-09-15","current":-0.211403,"twenty":-6.099709,"median":-0.36656,"eighty":-0.152775,"marketCap":4691110},{"date":"2023-09-22","current":-0.234028,"twenty":-6.072139,"median":-0.354312,"eighty":-0.153018,"marketCap":5193168},{"date":"2023-09-29","current":-0.234018,"twenty":-6.063862,"median":-0.348857,"eighty":-0.156417,"marketCap":5192950},{"date":"2023-10-06","current":-0.232051,"twenty":-5.995125,"median":-0.34336,"eighty":-0.157598,"marketCap":5149312},{"date":"2023-10-12","current":-0.202553,"twenty":-5.968328,"median":-0.339924,"eighty":-0.15851,"marketCap":4494738},{"date":"2023-10-20","current":-0.19862,"twenty":-5.943095,"median":-0.331533,"eighty":-0.159633,"marketCap":4407462},{"date":"2023-10-27","current":-0.17748,"twenty":-5.930583,"median":-0.330852,"eighty":-0.160014,"marketCap":3938351},{"date":"2023-11-03","current":-0.184854,"twenty":-5.9274,"median":-0.324715,"eighty":-0.1618,"marketCap":4101994},{"date":"2023-11-10","current":-0.183066,"twenty":-5.883138,"median":-0.323041,"eighty":-0.16188,"marketCap":4062301},{"date":"2023-11-17","current":-0.148342,"twenty":-5.836842,"median":-0.322209,"eighty":-0.159062,"marketCap":3342693},{"date":"2023-11-24","current":-0.145252,"twenty":-5.816945,"median":-0.321367,"eighty":-0.156171,"marketCap":3273054},{"date":"2023-12-01","current":-0.152463,"twenty":-5.786533,"median":-0.319083,"eighty":-0.153018,"marketCap":3435546},{"date":"2023-12-08","current":-0.154574,"twenty":-5.767656,"median":-0.313556,"eighty":-0.153398,"marketCap":3483133},{"date":"2023-12-15","current":-0.151432,"twenty":-5.745548,"median":-0.311311,"eighty":-0.152907,"marketCap":3412333},{"date":"2023-12-22","current":-0.13701,"twenty":-5.721826,"median":-0.309093,"eighty":-0.151382,"marketCap":3087348},{"date":"2023-12-29","current":-0.160704,"twenty":-5.704717,"median":-0.307079,"eighty":-0.150713,"marketCap":3621251},{"date":"2024-01-05","current":-0.13289,"twenty":-5.686169,"median":-0.30463,"eighty":-0.149893,"marketCap":2994496},{"date":"2024-01-12","current":-0.154996,"twenty":-5.645915,"median":-0.299233,"eighty":-0.149525,"marketCap":3492626},{"date":"2024-01-19","current":-0.130075,"twenty":-5.645915,"median":-0.294587,"eighty":-0.149317,"marketCap":2931067},{"date":"2024-01-26","current":-0.107281,"twenty":-5.645915,"median":-0.291072,"eighty":-0.148304,"marketCap":2417445},{"date":"2024-02-02","current":-0.109822,"twenty":-5.645915,"median":-0.287529,"eighty":-0.147383,"marketCap":2474697},{"date":"2024-02-09","current":-0.098674,"twenty":-5.607959,"median":-0.282312,"eighty":-0.145223,"marketCap":2223501},{"date":"2024-02-16","current":-0.102103,"twenty":-5.55025,"median":-0.279155,"eighty":-0.144221,"marketCap":2300750},{"date":"2024-02-23","current":-0.10333,"twenty":-5.509672,"median":-0.276176,"eighty":-0.14312,"marketCap":2328417},{"date":"2024-03-01","current":-0.17627,"twenty":-5.469944,"median":-0.269814,"eighty":-0.1414,"marketCap":3972006},{"date":"2024-03-08","current":-0.184779,"twenty":-5.456136,"median":-0.264382,"eighty":-0.141817,"marketCap":4163758},{"date":"2024-03-15","current":-0.263474,"twenty":-5.448325,"median":-0.265483,"eighty":-0.142326,"marketCap":5937046},{"date":"2024-03-22","current":-0.280241,"twenty":-5.424345,"median":-0.266038,"eighty":-0.14312,"marketCap":6314858},{"date":"2024-03-28","current":-0.430257,"twenty":-5.410574,"median":-0.270237,"eighty":-0.143784,"marketCap":7439885},{"date":"2024-04-05","current":-0.401151,"twenty":-5.408691,"median":-0.273386,"eighty":-0.144221,"marketCap":6936598},{"date":"2024-04-12","current":-0.383983,"twenty":-5.398613,"median":-0.27906,"eighty":-0.144221,"marketCap":6639732},{"date":"2024-04-19","current":-0.395667,"twenty":-5.355618,"median":-0.280241,"eighty":-0.144417,"marketCap":6841776},{"date":"2024-04-26","current":-0.379638,"twenty":-5.313802,"median":-0.281755,"eighty":-0.144869,"marketCap":6564604},{"date":"2024-05-03","current":-0.390395,"twenty":-5.304313,"median":-0.285031,"eighty":-0.145107,"marketCap":6750601},{"date":"2024-05-10","current":-0.388075,"twenty":-5.29008,"median":-0.288659,"eighty":-0.145166,"marketCap":6710484},{"date":"2024-05-17","current":-0.435575,"twenty":-5.284742,"median":-0.291072,"eighty":-0.145252,"marketCap":6564604},{"date":"2024-05-24","current":-0.395212,"twenty":-5.272584,"median":-0.294587,"eighty":-0.14587,"marketCap":5956284},{"date":"2024-05-31","current":-0.36206,"twenty":-5.261613,"median":-0.299233,"eighty":-0.146858,"marketCap":5456645},{"date":"2024-06-07","current":-0.370239,"twenty":-5.235194,"median":-0.30463,"eighty":-0.147173,"marketCap":5579913},{"date":"2024-06-14","current":-0.385771,"twenty":-5.205428,"median":-0.309003,"eighty":-0.147453,"marketCap":5814003},{"date":"2024-06-21","current":-0.324665,"twenty":-5.201974,"median":-0.310209,"eighty":-0.147491,"marketCap":4893065},{"date":"2024-06-28","current":-0.323842,"twenty":-5.199927,"median":-0.311257,"eighty":-0.147581,"marketCap":4880662},{"date":"2024-07-05","current":-0.266233,"twenty":-5.19519,"median":-0.310209,"eighty":-0.1479,"marketCap":4012437},{"date":"2024-07-12","current":-0.260576,"twenty":-5.171468,"median":-0.307079,"eighty":-0.148152,"marketCap":3927165},{"date":"2024-07-15","current":-0.265513,"twenty":-5.168752,"median":-0.305155,"eighty":-0.14819,"marketCap":4001584},{"date":"2024-08-02","current":-0.276639,"twenty":-5.166037,"median":-0.304893,"eighty":-0.148228,"marketCap":4169257},{"date":"2024-08-09","current":-0.292409,"twenty":-5.153832,"median":-0.303514,"eighty":-0.148484,"marketCap":4406936},{"date":"2024-08-16","current":-0.406658,"twenty":-5.128768,"median":-0.304072,"eighty":-0.148851,"marketCap":4308321},{"date":"2024-08-23","current":-0.447239,"twenty":-5.085306,"median":-0.306765,"eighty":-0.149088,"marketCap":4738261},{"date":"2024-08-30","current":-0.421897,"twenty":-5.049341,"median":-0.309651,"eighty":-0.149206,"marketCap":4469771},{"date":"2024-09-06","current":-0.443703,"twenty":-5.027235,"median":-0.311311,"eighty":-0.149403,"marketCap":4700797},{"date":"2024-09-13","current":-0.421055,"twenty":-5.016793,"median":-0.313556,"eighty":-0.149525,"marketCap":4460851},{"date":"2024-09-20","current":-0.413393,"twenty":-4.997102,"median":-0.317041,"eighty":-0.149549,"marketCap":4379680},{"date":"2024-09-27","current":-0.403795,"twenty":-4.959885,"median":-0.320252,"eighty":-0.149643,"marketCap":4277993},{"date":"2024-10-04","current":-0.354626,"twenty":-4.943621,"median":-0.322097,"eighty":-0.149693,"marketCap":3757070},{"date":"2024-10-11","current":-0.367508,"twenty":-4.93589,"median":-0.322424,"eighty":-0.149973,"marketCap":3893545},{"date":"2024-10-18","current":-0.370875,"twenty":-4.907704,"median":-0.323721,"eighty":-0.150314,"marketCap":3929224},{"date":"2024-10-25","current":-0.448081,"twenty":-4.894504,"median":-0.324715,"eighty":-0.150558,"marketCap":4747181},{"date":"2024-10-31","current":-0.422823,"twenty":-4.8868,"median":-0.325831,"eighty":-0.15118,"marketCap":4479583},{"date":"2024-11-08","current":-0.399922,"twenty":-4.801353,"median":-0.330577,"eighty":-0.151432,"marketCap":4236962},{"date":"2024-11-15","current":-0.334251,"twenty":-4.777584,"median":-0.331657,"eighty":-0.151432,"marketCap":3541208},{"date":"2024-11-22","current":-0.304894,"twenty":-4.768656,"median":-0.330593,"eighty":-0.151803,"marketCap":3005121},{"date":"2024-11-29","current":-0.333069,"twenty":-4.737768,"median":-0.330309,"eighty":-0.152331,"marketCap":3282818},{"date":"2024-12-06","current":-0.338719,"twenty":-4.711031,"median":-0.330647,"eighty":-0.152907,"marketCap":3338509},{"date":"2024-12-13","current":-0.358546,"twenty":-4.706277,"median":-0.331136,"eighty":-0.153018,"marketCap":3533927},{"date":"2024-12-20","current":-0.331353,"twenty":-4.687938,"median":-0.33141,"eighty":-0.153398,"marketCap":3265911},{"date":"2024-12-27","current":-0.312788,"twenty":-4.682846,"median":-0.330861,"eighty":-0.154111,"marketCap":3082925},{"date":"2025-01-03","current":-0.393507,"twenty":-4.673,"median":-0.331353,"eighty":-0.154523,"marketCap":3878518},{"date":"2025-01-10","current":-0.41964,"twenty":-4.653985,"median":-0.331657,"eighty":-0.154523,"marketCap":4136092},{"date":"2025-01-17","current":-0.353249,"twenty":-4.625819,"median":-0.333069,"eighty":-0.154523,"marketCap":3481716},{"date":"2025-01-24","current":-0.335995,"twenty":-4.589216,"median":-0.334114,"eighty":-0.154523,"marketCap":3311658},{"date":"2025-01-31","current":-0.268273,"twenty":-4.565681,"median":-0.333069,"eighty":-0.154574,"marketCap":2644176},{"date":"2025-02-07","current":-0.325103,"twenty":-4.563663,"median":-0.331533,"eighty":-0.154523,"marketCap":3204304},{"date":"2025-02-14","current":-0.307687,"twenty":-4.563663,"median":-0.330861,"eighty":-0.154523,"marketCap":3032645},{"date":"2025-02-21","current":-0.265114,"twenty":-4.563663,"median":-0.330325,"eighty":-0.154523,"marketCap":2613033},{"date":"2025-02-28","current":-0.410249,"twenty":-4.563663,"median":-0.330309,"eighty":-0.154564,"marketCap":4043526},{"date":"2025-03-07","current":-0.371546,"twenty":-4.563663,"median":-0.330861,"eighty":-0.154912,"marketCap":3662062},{"date":"2025-03-14","current":-0.317362,"twenty":-4.544648,"median":-0.330754,"eighty":-0.155482,"marketCap":3128011},{"date":"2025-03-21","current":-0.334779,"twenty":-4.539894,"median":-0.331353,"eighty":-0.156387,"marketCap":3299670},{"date":"2025-03-28","current":-0.309622,"twenty":-4.539894,"median":-0.331107,"eighty":-0.156583,"marketCap":3051718},{"date":"2025-04-04","current":-0.330415,"twenty":-4.539894,"median":-0.330647,"eighty":-0.15713,"marketCap":3163719},{"date":"2025-04-11","current":-0.30202,"twenty":-4.522118,"median":-0.330309,"eighty":-0.157598,"marketCap":2891837},{"date":"2025-04-17","current":-0.317508,"twenty":-4.517674,"median":-0.329688,"eighty":-0.15851,"marketCap":3040136},{"date":"2025-04-25","current":-0.344561,"twenty":-4.504116,"median":-0.329335,"eighty":-0.159429,"marketCap":3299166},{"date":"2025-05-02","current":-0.330415,"twenty":-4.479183,"median":-0.330309,"eighty":-0.159878,"marketCap":3163719},{"date":"2025-05-09","current":-0.327834,"twenty":-4.440063,"median":-0.330294,"eighty":-0.160428,"marketCap":3139003},{"date":"2025-05-16","current":-0.33476,"twenty":-4.406787,"median":-0.330415,"eighty":-0.161322,"marketCap":3114286},{"date":"2025-05-23","current":-0.321476,"twenty":-4.342993,"median":-0.330415,"eighty":-0.161774,"marketCap":2990703},{"date":"2025-05-30","current":-0.321476,"twenty":-4.287975,"median":-0.330415,"eighty":-0.161832,"marketCap":2990703},{"date":"2025-06-06","current":-0.33476,"twenty":-4.240906,"median":-0.330415,"eighty":-0.162375,"marketCap":3114286},{"date":"2025-06-13","current":-0.329446,"twenty":-4.203251,"median":-0.330415,"eighty":-0.16336,"marketCap":3064853},{"date":"2025-06-20","current":-0.33476,"twenty":-4.18791,"median":-0.330647,"eighty":-0.163773,"marketCap":3114286},{"date":"2025-06-27","current":-0.337417,"twenty":-4.177455,"median":-0.331107,"eighty":-0.164145,"marketCap":3139003},{"date":"2025-07-03","current":-0.33476,"twenty":-4.155145,"median":-0.330754,"eighty":-0.164815,"marketCap":3114286},{"date":"2025-07-11","current":-0.358672,"twenty":-4.155145,"median":-0.33141,"eighty":-0.165282,"marketCap":3336735},{"date":"2025-07-18","current":-0.340074,"twenty":-4.142061,"median":-0.33188,"eighty":-0.166912,"marketCap":3163719},{"date":"2025-07-25","current":-0.350701,"twenty":-4.047924,"median":-0.332103,"eighty":-0.167045,"marketCap":3262585},{"date":"2025-08-01","current":-0.324133,"twenty":-4.043597,"median":-0.332103,"eighty":-0.167379,"marketCap":3015420},{"date":"2025-08-08","current":-0.294908,"twenty":-3.953786,"median":-0.331657,"eighty":-0.167649,"marketCap":2743538},{"date":"2025-08-15","current":-0.294908,"twenty":-3.883183,"median":-0.331107,"eighty":-0.16776,"marketCap":2743538},{"date":"2025-08-22","current":-0.379328,"twenty":-3.848389,"median":-0.331657,"eighty":-0.167951,"marketCap":3771594},{"date":"2025-08-29","current":-0.411384,"twenty":-3.789045,"median":-0.332103,"eighty":-0.168231,"marketCap":4090317},{"date":"2025-09-05","current":-0.32976,"twenty":-3.658044,"median":-0.332434,"eighty":-0.16849,"marketCap":3278746},{"date":"2025-09-12","current":-0.32483,"twenty":-3.602984,"median":-0.332103,"eighty":-0.168555,"marketCap":3229727},{"date":"2025-09-19","current":-0.205692,"twenty":-3.530479,"median":-0.331381,"eighty":-0.1694,"marketCap":2045158},{"date":"2025-09-26","current":-0.199097,"twenty":-3.491437,"median":-0.330647,"eighty":-0.169733,"marketCap":1979583},{"date":"2025-10-03","current":-0.253654,"twenty":-3.418931,"median":-0.330415,"eighty":-0.170769,"marketCap":2522038},{"date":"2025-10-10","current":-0.440813,"twenty":-3.35758,"median":-0.330415,"eighty":-0.17133,"marketCap":4382929},{"date":"2025-10-17","current":-0.492983,"twenty":-3.324116,"median":-0.330531,"eighty":-0.171407,"marketCap":4901641},{"date":"2025-10-24","current":-0.383014,"twenty":-3.296229,"median":-0.331353,"eighty":-0.171737,"marketCap":3808241},{"date":"2025-10-31","current":-0.319543,"twenty":-3.290652,"median":-0.331533,"eighty":-0.171819,"marketCap":3177160},{"date":"2025-11-07","current":-0.314851,"twenty":-3.290652,"median":-0.33141,"eighty":-0.172021,"marketCap":3130513},{"date":"2025-11-14","current":-0.284617,"twenty":-3.223723,"median":-0.330754,"eighty":-0.172809,"marketCap":2829901},{"date":"2025-11-21","current":-0.311539,"twenty":-3.206991,"median":-0.330415,"eighty":-0.173011,"marketCap":3032037},{"date":"2025-11-28","current":-0.352085,"twenty":-3.173527,"median":-0.330647,"eighty":-0.173046,"marketCap":3426653},{"date":"2025-12-05","current":-0.37478,"twenty":-3.134485,"median":-0.331381,"eighty":-0.173803,"marketCap":3647535},{"date":"2025-12-12","current":-0.333683,"twenty":-3.089866,"median":-0.332103,"eighty":-0.174484,"marketCap":3247560},{"date":"2025-12-16","current":-0.328776,"twenty":-3.067557,"median":-0.332103,"eighty":-0.17461,"marketCap":3199802}],"updateTime":1765972007372},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ENVB\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2574000351","title":"Enveric Biosciences Inc announces date for special stockholder meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2574000351","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574000351?lang=en_us&edition=fundamental","pubTime":"2025-10-11 05:11","pubTimestamp":1760130683,"startTime":"0","endTime":"0","summary":"Enveric Biosciences Inc. has announced that it will hold a Special Meeting of Stockholders on December 11, 2025. The meeting will be conducted virtually via a live webcast. Among the matters to be addressed is a proposal to amend the company's Amended and Restated Certificate of Incorporation by adding a new paragraph to Article IV.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Enveric Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on October 10, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251010:nNDL6Wc60P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ENVB","BK4007"],"gpt_icon":0},{"id":"2572510367","title":"Enveric Biosciences completes key manufacturing milestones for EB-003","url":"https://stock-news.laohu8.com/highlight/detail?id=2572510367","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572510367?lang=en_us&edition=fundamental","pubTime":"2025-10-02 21:10","pubTimestamp":1759410612,"startTime":"0","endTime":"0","summary":"Enveric Biosciences (ENVB) announced significant progress in the chemistry, manufacturing, and controls development of its lead candidate, EB-003. ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/enveric-biosciences-completes-key-manufacturing-milestones-for-eb-003-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/enveric-biosciences-completes-key-manufacturing-milestones-for-eb-003-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4108","BK4077","EB","ENVB"],"gpt_icon":0},{"id":"2572120315","title":"Enveric Biosciences Achieves Key Manufacturing Milestones for EB-003, Paving Way for Human Clinical Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2572120315","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572120315?lang=en_us&edition=fundamental","pubTime":"2025-10-02 20:45","pubTimestamp":1759409121,"startTime":"0","endTime":"0","summary":"Enveric Biosciences Inc. has announced significant advancements in the development of its lead candidate, EB-003, a next-generation small molecule targeting neuropsychiatric conditions. The company has successfully completed key chemistry, manufacturing, and controls  milestones, including the identification and production of a pharmaceutically compatible salt form of EB-003, which may improve drug effectiveness and stability. Additionally, Enveric developed a scalable and reproducible synthetic route and produced a 1-kilogram batch of EB-003 to support upcoming Investigational New Drug  application activities. These results, which support the planned initiation of human clinical trials, have been announced by the company and will further enable IND-enabling studies and future regulatory submissions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated co","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251002:nNDL9xKmpV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EXSR","ENVB","BK4211","BK4007"],"gpt_icon":0},{"id":"2572058512","title":"Enveric Biosciences Successfully Completes Key Manufacturing Milestones in Support of Planned Ind and Clinical Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2572058512","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572058512?lang=en_us&edition=fundamental","pubTime":"2025-10-02 20:45","pubTimestamp":1759409100,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251002:nTUA4MLXRW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ENVB","BK4007"],"gpt_icon":0},{"id":"2571555366","title":"BRIEF-Enveric Biosciences Says Selling Stockholders Are Offering On A Resale Basis An Aggregate Of 4.8 Million Shares Of Common Stock - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2571555366","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571555366?lang=en_us&edition=fundamental","pubTime":"2025-09-30 06:13","pubTimestamp":1759184006,"startTime":"0","endTime":"0","summary":"BRIEF-Enveric Biosciences Says Selling Stockholders Are Offering On A Resale Basis An Aggregate Of 4.8 Million Shares Of Common Stock - SEC FilingSept 29  - Enveric Biosciences Inc ENVB.O:ENVERIC BIOSCIENCES INC: SELLING STOCKHOLDERS ARE OFFERING ON A RESALE BASIS AN AGGREGATE OF 4.8 MILLION SHARES OF COMMON STOCK - SEC FILINGSource text: [ID:n0001493152-25-016013]Further company coverage: ENVB.O ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250929:nFWN3VG0I7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ENVB","BK4007"],"gpt_icon":0},{"id":"2571368901","title":"Enveric Biosciences files to sell 5.02M shares of common stock for holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2571368901","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571368901?lang=en_us&edition=fundamental","pubTime":"2025-09-30 04:40","pubTimestamp":1759178441,"startTime":"0","endTime":"0","summary":"16:35 EDT Enveric Biosciences (ENVB) files to sell 5.02M shares of common stock for holders Published first on TheFly – the ultimate source for rea...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/enveric-biosciences-files-to-sell-5-02m-shares-of-common-stock-for-holders-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/enveric-biosciences-files-to-sell-5-02m-shares-of-common-stock-for-holders-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ENVB","BK4007"],"gpt_icon":0},{"id":"2571697368","title":"Enveric Biosciences Inc: Selling Stockholders Are Offering on a Resale Basis an Aggregate of 4.8 Mln Shares of Common Stock - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2571697368","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571697368?lang=en_us&edition=fundamental","pubTime":"2025-09-30 04:39","pubTimestamp":1759178367,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250929:nFWN3VG0I7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","ENVB"],"gpt_icon":0},{"id":"2568428529","title":"Enveric Biosciences Closes Warrant Exercise Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2568428529","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568428529?lang=en_us&edition=fundamental","pubTime":"2025-09-19 05:00","pubTimestamp":1758229241,"startTime":"0","endTime":"0","summary":"Enveric Biosciences ( ($ENVB) ) has provided an announcement. On September 17, 2025, Enveric Biosciences entered into warrant exercise inducement o...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/enveric-biosciences-closes-warrant-exercise-deal?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/enveric-biosciences-closes-warrant-exercise-deal?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","ENVB"],"gpt_icon":0},{"id":"2568120494","title":"Enveric Biosciences Expects to Receive $2.2 Million From Exercise of Warrants","url":"https://stock-news.laohu8.com/highlight/detail?id=2568120494","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568120494?lang=en_us&edition=fundamental","pubTime":"2025-09-17 22:00","pubTimestamp":1758117607,"startTime":"0","endTime":"0","summary":"Enveric Biosciences  said Wednesday it expects to receive gross proceeds of about $2.2 million from the exercise of certain warrants to buy up to roughly 2.4 million common shares at a reduced exercise price of $0.915 per share.The warrants were originally issued in February, having an exercise price of $3 per share, the company said.Enveric said that in consideration for the immediate exercise of the warrants for cash, it will issue new warrants to buy up to more than 4.8 million common shares at an exercise price of $0.915 per share.The company said the net proceeds from the private placement of the new warrants, expected to close on or about Thursday, will be used for product development, working capital and general corporate purposes.Enveric shares were down 30% in recent trading.Price: 0.64, Change: -0.28, Percent Change: -30.05","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","ENVB"],"gpt_icon":0},{"id":"2567297488","title":"Enveric Biosciences to Submit Investigational New Drug Application for Depression Medication","url":"https://stock-news.laohu8.com/highlight/detail?id=2567297488","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567297488?lang=en_us&edition=fundamental","pubTime":"2025-09-16 21:21","pubTimestamp":1758028871,"startTime":"0","endTime":"0","summary":"Enveric Biosciences  said Tuesday that it will streamline its regulatory pathway and proceed to an Investigational New Drug, or IND, application, for its depression and anxiety treatment candidate, EB-003.The company said it expects to file the IND application in early 2026.Enveric said that in response to its Pre-Investigational New Drug Type B meeting request to the FDA, the regulator indicated that the company's queries were a matter for review under an IND application and recommended that it proceed with the submission.Shares of the company were up 1.1% in recent Tuesday premarket activity.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","ENVB"],"gpt_icon":0},{"id":"2567448847","title":"Enveric Biosciences receives FDA response, streamlines path for EB-003","url":"https://stock-news.laohu8.com/highlight/detail?id=2567448847","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567448847?lang=en_us&edition=fundamental","pubTime":"2025-09-16 21:00","pubTimestamp":1758027608,"startTime":"0","endTime":"0","summary":"Enveric Biosciences (ENVB) announced that it has received a written response from the FDA to its request for a pre-investigational new drug Type B ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/enveric-biosciences-receives-fda-response-streamlines-path-for-eb-003-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/enveric-biosciences-receives-fda-response-streamlines-path-for-eb-003-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ENVB","BK4077","EB","BK4108","BK4007"],"gpt_icon":0},{"id":"2567100898","title":"Enveric Biosciences Receives FDA Response and Streamlines Plans for Eb-003 Ind Submission","url":"https://stock-news.laohu8.com/highlight/detail?id=2567100898","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567100898?lang=en_us&edition=fundamental","pubTime":"2025-09-16 20:45","pubTimestamp":1758026700,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250916:nTUABRSGXD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ENVB","BK4007"],"gpt_icon":0},{"id":"2567100362","title":"Enveric Biosciences Inc - Expects to File Ind for Eb-003 in Early 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2567100362","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567100362?lang=en_us&edition=fundamental","pubTime":"2025-09-16 20:45","pubTimestamp":1758026700,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250916:nTUABRSGXD:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ENVB","BK4007"],"gpt_icon":0},{"id":"2564839583","title":"Enveric Biosciences to Present at H.C. Wainwright 27th Annual Global Investment Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2564839583","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564839583?lang=en_us&edition=fundamental","pubTime":"2025-09-03 20:31","pubTimestamp":1756902704,"startTime":"0","endTime":"0","summary":"Enveric Biosciences Inc.  is set to present at the H.C. Wainwright 27th Annual Global Investment Conference, which will take place virtually from September 8-10, 2025. During the event, CEO Joseph Tucker, Ph.D., will deliver a prerecorded presentation providing updates on the company's pipeline of novel neuroplastogenic small-molecule therapeutics for treating depression, anxiety, and addiction disorders, including their lead candidate EB-003. The presentation highlights EB-003's therapeutic benefits while minimizing hallucinatory effects and its potential dual-targeting mechanism of action.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Enveric Biosciences Inc. published the original content used to generate this news brief via Busine","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250903:nNDLb655DL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4211","BK4007","ENVB","EXSR"],"gpt_icon":0},{"id":"2564020118","title":"Enveric Biosciences Relocates Headquarters to Cambridge, MA to Advance Neuroplastogen Research","url":"https://stock-news.laohu8.com/highlight/detail?id=2564020118","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564020118?lang=en_us&edition=fundamental","pubTime":"2025-09-02 20:30","pubTimestamp":1756816226,"startTime":"0","endTime":"0","summary":"Enveric Biosciences Inc., a biotechnology company focused on neuroplastogenic small molecules for psychiatric and neurological disorders, has announced the relocation of its corporate headquarters to Cambridge, Massachusetts. This move aims to enhance collaboration, talent recruitment, and visibility within the prominent Cambridge life sciences cluster. The relocation supports Enveric's efforts to advance its lead molecule, EB-003, towards clinical trials.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Enveric Biosciences Inc. published the original content used to generate this news brief via Business Wire  on September 02, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250902:nNDLb6PSbJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EXSR","BK4211","ENVB","BK4007"],"gpt_icon":0},{"id":"2563072124","title":"Enveric Biosciences Faces Nasdaq Delisting Risk Due to Stockholders' Equity Shortfall","url":"https://stock-news.laohu8.com/highlight/detail?id=2563072124","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2563072124?lang=en_us&edition=fundamental","pubTime":"2025-08-30 05:11","pubTimestamp":1756501868,"startTime":"0","endTime":"0","summary":"Enveric Biosciences Inc. has announced receiving a deficiency letter from the Nasdaq Stock Market, indicating non-compliance with the minimum stockholders' equity requirement for continued listing on the Nasdaq Capital Market. As per Nasdaq Listing Rule 5550, companies must maintain stockholders' equity of at least $2.5 million. Enveric reported stockholders' equity of $2,184,769 for the period ending June 30, 2025. The company has until October 10, 2025, to submit a compliance plan to rectify this issue. If accepted, Nasdaq may grant an extension of up to 180 days to meet the requirement. Failure to submit an acceptable plan could lead to further regulatory actions. Enveric is currently exploring options to regain compliance.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as f","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250829:nNDLcfK5s4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ENVB","BK4007"],"gpt_icon":0},{"id":"2562032690","title":"Enveric Biosciences Inc - Completes Pre-Ind Dose Range Finding Studies for Lead Candidate Eb-003","url":"https://stock-news.laohu8.com/highlight/detail?id=2562032690","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562032690?lang=en_us&edition=fundamental","pubTime":"2025-08-28 20:31","pubTimestamp":1756384291,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250828:nFWN3UK0W0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ENVB","BK4007"],"gpt_icon":0},{"id":"2562326530","title":"Enveric Biosciences Advances Lead Candidate EB-003 Towards Clinical Trials with Successful Pre-IND Study Completion","url":"https://stock-news.laohu8.com/highlight/detail?id=2562326530","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562326530?lang=en_us&edition=fundamental","pubTime":"2025-08-28 20:30","pubTimestamp":1756384228,"startTime":"0","endTime":"0","summary":"Enveric Biosciences Inc., a biotechnology company specializing in the development of novel neuroplastogenic small-molecule therapeutics, has successfully completed pre-IND Dose Range Finding  toxicology studies for its leading drug candidate, EB-003. The studies, conducted in two preclinical species, have established the Maximum Tolerated Dose  of EB-003, which targets neuropsychiatric indications such as depression and post-traumatic stress disorder . The results, which confirmed oral bioavailability and brain penetration, were noted for dose-dependent increases in plasma concentrations and CNS-related effects, suggesting potential on-target activity. These findings are pivotal for advancing EB-003 towards IND-enabling studies and First-in-Human clinical trials. Enveric plans to proceed with definitive toxicology, safety pharmacology, and genotoxicity studies to support an IND submission to the FDA. No specific future presentation of these results has been announced.Disclaimer: This n","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250828:nNDLl5Hq9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ENVB","EXSR","BK4007","BK4211"],"gpt_icon":0},{"id":"2559952825","title":"Enveric Biosciences Q2 EPS $(0.97) Up From $(3.72) YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2559952825","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559952825?lang=en_us&edition=fundamental","pubTime":"2025-08-14 20:14","pubTimestamp":1755173698,"startTime":"0","endTime":"0","summary":"Enveric Biosciences (NASDAQ:ENVB) reported quarterly losses of $(0.97) per share. This is a 73.92 percent increase over losses of $(3.72) per share from the same period last year.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/08/47119263/enveric-biosciences-q2-eps-0-97-up-from-3-72-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ENVB"],"gpt_icon":0},{"id":"2559954250","title":"Enveric Biosciences Reports Q2 2025 Net Loss of $2.5M, EPS at $0.97, Up from $1.9M Loss, $3.72 EPS in Q2 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2559954250","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559954250?lang=en_us&edition=fundamental","pubTime":"2025-08-14 20:01","pubTimestamp":1755172901,"startTime":"0","endTime":"0","summary":"Enveric Biosciences Inc.  reported its financial results for the second quarter ending June 30, 2025. The company disclosed a net loss attributable to common stockholders of $2.5 million, or $0.97 per share, compared to a net loss of $1.9 million, or $3.72 per share, for the same period in 2024. The net loss for the quarter included approximately $0.2 million in non-cash expenses related to stock-based compensation and other non-cash charges. As of June 30, 2025, Enveric held cash and cash equivalents totaling $2.8 million and raised net proceeds of $4.9 million for the first half of the year. CEO Joseph Tucker highlighted significant progress in the development of EB-003, the company's lead drug candidate, noting the confirmation of its dual mechanism of action involving the 5-HTA and 5-HTB receptors. This advancement positions EB-003 as a potential first-in-class therapeutic candidate. Enveric also expanded its intellectual property portfolio, securing a new patent grant and patent a","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250814:nNDL7tnqLY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EXSR","ENVB"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":47,"code":"91000000","status":"200"}]}}